The Whittingham Cancer Center, Norwalk Hospital is a clinical research site located in Norwalk, Connecticut, United States 06856.
Crixeo Clinical Trials Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
The Whittingham Cancer Center, Norwalk Hospital has participated in 3 clinical trials.
Therapeutic areas: HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.
Sponsors: Seagen Inc., SciClone Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Connecticut · View every site in Norwalk
Trust Score: 81/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The Whittingham Cancer Center, Norwalk Hospital has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The Whittingham Cancer Center, Norwalk Hospital has 3 clinical trials on record. Their work covers HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.
The Whittingham Cancer Center, Norwalk Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.